From 1996-2020, the innovation system created by Bayh-Dole bolstered U.S. economic output by up to $1.9 trillion, supported 6.5 million jobs, and helped lead to more than 17,000 start-up companies.
“The Bayh-Dole Act has indisputably helped the U.S. life sciences sector become the envy of the world. Over 200 drugs and vaccines have been developed through the kinds of public-private partnerships that Bayh-Dole incentivizes."
“The Bayh-Dole Act delicately balanced the interests of the federal government, industry, and academia by decentralizing the licensing of federally funded R&D…This simple fix ignited the fire of American innovation."
“If you make an interest in universities to license [inventions] out, then you get new companies and innovation will be useful for the public. That's why [the Bayh-Dole Act] was so critical."
“The Bayh-Dole Act is among the most successful laws of economic policy in U.S. history...By giving universities and other research institutions the right to keep title to their patents and control their licensing, Bayh-Dole ushered in an era of remarkable innovation."
“In the last 40 years, the ingenuity of American companies has transformed almost every aspect of our lives. The Bayh-Dole Act made this possible."
“The Bayh-Dole Act was visionary 40 years ago, and it is integral to our country's innovation engine today and for the future."
“The Bayh Dole Act has been the most important game-changer [in American innovation] because it has allowed the collective intellectual firepower of universities to be part of an effort to take an idea from conception and turn it ultimately into a product or service that benefits the public."
“For 40 years, Bayh-Dole has created a policy environment where scientific innovation -- kickstarted by federal research grants but overwhelmingly funded by the private sector -- can flourish."
“The Bayh-Dole Act has been hugely successful in facilitating the development of commercially available medical treatments and other products and maximizing taxpayer benefit for government-funded research."
“The law we passed is about encouraging a partnership that spurs advances to help Americans. We are proud to say it's working."
"Federal funding distinguishes U.S. universities globally, but it's collaborations with industry and investors that transform academic innovations into practical products. The Bayh-Dole Act has sustained these fruitful partnerships for over 40 years, and the Bayh-Dole Coalition will ensure the law continues to do so for decades to come."
"The success of the U.S. economy is inextricably linked to the preservation of the Bayh-Dole Act. I'm proud to support the Bayh-Dole Coalition and its mission of protecting this landmark law."
"The work of the Bayh-Dole Coalition has been critical to informing Congress, White House officials, and the media about the bipartisan legacy of the Bayh-Dole Act and the outsized role it has played in boosting U.S. innovative prowess and leadership. The Bayh-Dole Coalition is a focused and powerfully effective initiative whose mission is central U.S. competitiveness and innovation, and SBE Council is honored to be a member."
Empowers universities, small businesses and non-profit institutions to take ownership of inventions made during federally-funded research, so they can license these basic inventions for further applied research and development and broader public use.
Encourages private-sector investment needed to turn basic government-funded research into tested and approved products, requires these products to be manufactured domestically and ensures royalties for universities to further advance basic research and education.
Allows the government to require additional licensing of inventions arising from its research if the invention is not being made available for public use or during public health or other national emergencies.
Enacted by Congress with strong bipartisan support to ensure basic innovations discovered through federal research are developed into real-life products, including approved therapies that reduce suffering, treat the sick and improve the lives of patients.